Corvus Pharmaceuticals
Presença
Corvus Pharmaceuticals é uma empresa listada sob o símbolo CRVS (US).
Executivos
Veja o organograma con seus 12 executivos principais
Biografias mais buscadas da Corvus Pharmaceuticals
- Richard Miller, Chief Executive Officer and Chairman of the Board
- Ian Clark, Director
- Linda Grais, Director
Recentes movimentos de executivos em Corvus Pharmaceuticals
- Jeffrey Arcara, ingressou na Companhia como Chief Business Officer (Notícia publicada em 7 de fevereiro de 2024).
- Edith Mitchell, Director, aleceu. Sentimos muitíssimo (Notícia publicada em 24 de janeiro de 2024).
Criar um alerta
para seguir os movimentos de executivos da Corvus Pharmaceuticals.
Farmacêutica
Corvus Pharmaceuticals possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Corvus Pharmaceuticals
- Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results | Corvus Pharmaceuticals
- Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024 | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma | Corvus Pharmaceuticals
- Press Releases | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer | Corvus Pharmaceuticals
- New Data from Corvus Phase 1 Study of CPI-006 Continues to Support its Potential as a Treatment for COVID-19 | Corvus Pharmaceuticals
- Corvus Pharmaceuticals Announces Co-Founding of Angel Pharmaceuticals in China | Corvus Pharmaceuticals
- View more press releases Close
Redes sociais sobre Corvus Pharmaceuticals
- Corvus Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Corvus Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Richard Miller 
Ligue para a Corvus Pharmaceuticals em +1 650...
